CCI
ARRY

Columbus Circle Investors’s Array Biopharma Inc ARRY Stock Holding History

Columbus Circle Investors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-200,100
Closed -$1.35M – 325
2016
Q3 		$1.35M Buy
+200,100
New +$774K 0.01% 245

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Columbus Circle Investors's ARRY Position: Q3 2019 in Review

Columbus Circle Investors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 553,980 shares — an estimated $25.7M sold.

Columbus Circle Investors first reported a position in ARRY in Q3 2013 and held it in 24 quarters. The position peaked at $27.3M in Q2 2018. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Columbus Circle Investors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Columbus Circle Investors sold 553,980 Array Biopharma Inc shares in Q3 2019, an estimated $25.7M.
  • Columbus Circle Investors first reported a position in Array Biopharma Inc in Q3 2013 and held it in 24 quarters.
  • Columbus Circle Investors's Array Biopharma Inc position peaked at $27.3M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Columbus Circle Investors's 13F filing for Q3 2019, filed 29 Oct 2019.